
Key Points
- Session agenda (Sept. 29): The second-reading calendar included Bill 1-38, aimed at adjusting annual appropriations for the Guam Cancer Trust Fund (GCTF).
- Tax design: Bill 3-38 proposes a 20% excise tax at the retail level on e-cigarette (ENDS) products, with designated allocations for enforcement and public health uses.
- Funding assurance debate: Lawmakers and stakeholders have highlighted GCTF shortfalls, advocating stable “sin tax” streams— including portions of alcohol and tobacco (e-cigarette) taxes—earmarked for the trust.
- Context: Guam has repeatedly discussed taxing e-cigarettes to offset declining revenues from traditional tobacco; related proposals continue to advance in the current legislature.
2Firsts, September 30, 2025 — Citing Citizenportal, Guam’s 38th Legislature advanced Bill 1-38 to second reading during its September 29 regular session, focusing on securing stable annual funding for the Guam Cancer Trust Fund (GCTF) to support cancer patients and their families. Session materials indicate Bill 1-38 seeks to revise appropriation provisions to raise or lock in yearly GCTF funding levels.
On the revenue side, lawmakers underscored the shift from conventional cigarettes to vaping and the need to tax e-cigarette products to supplement public health financing. The previously introduced Bill 3-38 (ENDS Excise Act of 2025) would impose a 20% retail excise tax on ENDS products and specify the allocation of proceeds to public health and youth tobacco education and prevention, tax enforcement, and Guam Memorial Hospital (GMH) operations and maintenance. This framework is intended to create incremental fiscal space for health programs.
At the same time, recent hearings and media coverage have called for statutory mechanisms to guarantee GCTF receives a defined share of “sin tax” revenues (alcohol and tobacco, including e-cigarettes), to address longstanding funding gaps. Some proposals envision dedicating a set proportion—or establishing a floor amount—of such revenues to GCTF to shield cancer services from annual budget cycles.
According to the legislature’s published agenda, the September 29 session also advanced measures on budget and personnel, as well as public health and education. While Bill 3-38 is a previously filed tax bill, its tax base and earmarking scheme remain central to lawmakers’ discussion of health-care financing. Any direct dedication of a portion of e-cigarette tax receipts to GCTF would still require further legislation or amendments to specify the revenue transfer.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com